BridgeBio Pharma BBIO
NASDAQ BBIO
$79.54 +0.87 (+1.11%)
At close: Nov 11, 2026 · 4:00 PM EST

BridgeBio Pharma (BBIO) Raw Materials (2025 - 2026)

Updated

BridgeBio Pharma (BBIO) reported Raw Materials of $30 million for Q3 2026, up 81.8% from $16.51 million a year earlier and up 7.7% from the prior quarter.

Analysis

BridgeBio Pharma (BBIO) Raw Materials (2025 - 2026) Analysis & Trends

At the end of FY2025, BridgeBio Pharma posted Raw Materials of $15 million.

  • Per Business Quant data, the three quarters before Q3 2026 came in at $27.85 million (Q2 2026), $15.79 million (Q1 2026) and $15 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 BridgeBio Pharma 15.42 Bn 11.64 Bn 332.72 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 30.00 Mn
Jun 30, 2026 27.85 Mn
Mar 31, 2026 15.79 Mn
Dec 31, 2025 15.00 Mn
Sep 30, 2025 16.51 Mn
Jun 30, 2025 11.46 Mn
API Access

BridgeBio Pharma Raw Materials API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=raw-materials&ticker=BBIO&period=max&api_key=YOUR_API_KEY